January 22nd 2021, 7:00pm
The priority review will focus on retifanlimab for the treatment of certain adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal who did not tolerate platinum-based chemotherapy. Currently, according to Incyte, there are no approved treatments for this patient population.
August 24th 2020, 9:00pm
To halt the rise of anal cancer, everyone eligible needs to be vaccinated against HPV, which causes most cases of the disease.
February 25th 2020, 12:40am
Sexual and gender minorities are not receiving the same standard of clinical care as other patients with cancer.
February 13th 2020, 3:36am
HPV and Anal cancer are associated with one another, here's what you need to know.
June 7th 2019, 10:00pm
From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.
October 6th 2018, 1:05am
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
August 7th 2018, 8:13pm
Research continues to drive the oncology field.
July 25th 2018, 4:58pm
A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.
February 27th 2018, 7:38pm
Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.
August 3rd 2017, 5:34pm
More personalized approaches are being developed to treat patients with metastatic disease.
Many Women Are Satisfied After 'Going Flat' Post-Mastectomy, Study Finds
The MRI Problem: Worsening Symptoms in Survivors Can Lead to an Unnerving Feeling
Oncologist Turned Caregiver Offers Guidance About Women's Cancers
CURE’s Clinical Trial Corner: February 2021
